Medtronic credits heart-surgery-device growth as profit tops analyst estimates - MarketWatch
1. MDT revenue grew nearly 3%, driven by heart-surgery devices. 2. Pulsed-field ablation products saw over 20% revenue increase. 3. Adjusted earnings per share were $1.39, beating estimates. 4. 2025 earnings outlook aligns closely with analyst projections. 5. MDT stock increased 16.2% in 2025, outperforming S&P 500.